#India's #pharmasector is projected to grow 8-10% this fiscal, with exports accounting for 53% of #revenue and steady domestic demand. Operating margins are expected to improve to 22.5% in FY25, supported by easing #US pricing pressures and stable input costs. Chronic therapies drive domestic growth.

India overtakes #Japan to become the third most powerful country in the world after the #US and #China.

Amazon cancels inventory orders for several products manufactured in China, Vietnam, and Thailand, amid the intensifying US-China trade war.

#Amazon #China #US #TradeWar #TrumpTariffs #Tariffs

#India gets a breather as the #US spares smartphones from steep #China tariffs, giving #iPhones made in India a cost edge—for now. But without faster #supplychain localisation, input duty tweaks, and a clear post-PLI roadmap, the advantage may slip.

#China now faces up to a 245% #tariff on imports to the #US as a result of its retaliatory actions, the #WhiteHouse says after #Trump signs an executive order to investigate security risks over imported critical #minerals.

The #US and #China report “substantial progress” after two days of talks in Switzerland aimed at de-escalating a trade war.

#US Senate Bill proposes steep sanctions on Russian crude, threatening #India’s $50 bn imports that make up 35% of its crude bill.

Russian oil supplies, discounted and comprising 39% of May imports, face risk amid tightening US measures.